Description
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
This trial is available at multiple Sutter Locations. Pleasecontact one of the following about Study N0577
SanFrancisco: ClinicalResearch@sutterhealth.org
PaloAlto/Santa Cruz: Tanya Pozniansky pozniat@sutterhealth.org
PAMF/Fremont:Tanya Pozniansky pozniat@sutterhealth.org
EastBay: Vivian Leong, RN Leongv@sutterhealth.org
Sacramento: SIMR@sutterhealth.org
Modesto: Stephanie Edmondson edmondsons@sutterhealth.org
Solano-VallejoCancer Center: Stephanie Gonzales gonzals1@sutterhealth.org
SanMateo: Stephanie Casal CasalSL@sutterhealth.org andBonnie Chan ChanBW@sutterhealth.org